Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder

Child Psychiatry and Human Development

Volumn 39, Issue 2, 2008, Pages 201-209

  Lee, Moon Soo ^a   Yang, Jae Won ^a   Ko, Young Hoon ^a   Han, Changsu ^a   Kim, Seung Hyun ^a   Lee, Min Soo ^a   Joe, Sook Haeng ^a   Jung, In Kwa ^a  

^a Korea University Ansan Hospital   (South Korea)

Author keywords

Attention deficit disorder with hyperactivity; Bupropion; Dehydroepiandrosterone sulfate; Methylphenidate

Indexed keywords

AMFEBUTAMONE; HYDROCORTISONE; METHYLPHENIDATE; PRASTERONE SULFATE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; RATING SCALE; SCHOOL CHILD; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 40449088338     PISSN: 0009398X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10578-007-0081-6     Document Type: Article

References (25)

1. 1. J Elia PJ Ambrosini JL Rapoport 1999 Treatment of attention-deficit-hyperactivity disorder N Engl J Med 340 10 780 788 10072414 10.1056/NEJM199903113401007 Elia J, Ambrosini PJ, Rapoport JL (1999) Treatment of attention-deficit-hyperactivity disorder. N Engl J␣Med 340(10):780–788
2. 2. AF Arnsten 2006 Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways J Clin Psychiatry 67 Suppl 8 7 12 16961424 Arnsten AF (2006) Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. J␣Clin Psychiatry 67(Suppl 8):7–12
3. 3. S Timimi E Taylor 2004 ADHD is best understood as a cultural construct Br J Psychiatry 184 8 9 14702221 10.1192/bjp.184.1.8 Timimi S, Taylor E (2004) ADHD is best understood as a cultural construct. Br J Psychiatry 184:8–9
4. 4. BO Dubrovsky 2005 Steroids, neuroactive steroids and neurosteroids in psychopathology Prog Neuropsychopharmacol Biol Psychiatry 29 2 169 192 15694225 10.1016/j.pnpbp.2004.11.001 Dubrovsky BO (2005) Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog Neuropsychopharmacol Biol Psychiatry 29(2):169–192
5. 5. RD Strous B Spivak R Yoran-Hegesh R Maayan E Averbuch M Kotler 2001 Analysis of neurosteroid levels in attention deficit hyperactivity disorder Int J Neuropsychopharmacol 4 3 259 264 11602031 10.1017/S1461145701002462 Strous RD, Spivak B, Yoran-Hegesh R, Maayan R, Averbuch E, Kotler M et al (2001) Analysis of neurosteroid levels in attention deficit hyperactivity disorder. Int J Neuropsychopharmacol 4(3):259–264
6. 6. R Maayan R Yoran-Hegesh R Strous A Nechmad E Averbuch A Weizman 2003 Three-month treatment course of methylphenidate increases plasma levels of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) in attention deficit hyperactivity disorder Neuropsychobiology 48 3 111 115 14586159 10.1159/000073626 Maayan R, Yoran-Hegesh R, Strous R, Nechmad A, Averbuch E, Weizman A et al (2003) Three-month treatment course of methylphenidate increases plasma levels of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) in attention deficit hyperactivity disorder. Neuropsychobiology 48(3):111–115
7. 7. I Charalampopoulos E Dermitzaki L Vardouli C Tsatsanis C Stournaras AN Margioris 2005 Dehydroepiandrosterone sulfate and allopregnanolone directly stimulate catecholamine production via induction of tyrosine hydroxylase and secretion by affecting actin polymerization Endocrinology 146 8 3309 3318 15860555 10.1210/en.2005-0263 Charalampopoulos I, Dermitzaki E, Vardouli L, Tsatsanis C, Stournaras C, Margioris AN et al (2005) Dehydroepiandrosterone sulfate and allopregnanolone directly stimulate catecholamine production via induction of tyrosine hydroxylase and secretion by affecting actin polymerization. Endocrinology 146(8):3309–3318
8. 8. ND Volkow GJ Wang JS Fowler SJ Gatley J Logan YS Ding 1998 Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate Am J Psychiatry 155 10 1325 1331 9766762 Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS et al (1998) Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155(10):1325–1331
9. 9. RR Gainetdinov WC Wetsel SR Jones ED Levin M Jaber MG Caron 1999 Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity Science 283 5400 397 401 9888856 10.1126/science.283.5400.397 Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG (1999) Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283(5400):397–401
10. 10. RM Ferris FL Tang 1979 Comparison of the effects of the isomers of amphetamine, methylphenidate and deoxypipradrol on the uptake of l-[3H]norepinephrine and [3H]dopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus J Pharmacol Exp Ther 210 3 422 428 39160 Ferris RM, Tang FL (1979) Comparison of the effects of the isomers of amphetamine, methylphenidate and deoxypipradrol on the uptake of l-[3H]norepinephrine and [3H]dopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus. J Pharmacol Exp Ther 210(3):422–428
11. 11. TD Challman JJ Lipsky 2000 Methylphenidate: its pharmacology and uses Mayo Clin Proc 75 7 711 721 10907387 10.4065/75.7.711 Challman TD, Lipsky JJ (2000) Methylphenidate: its pharmacology and uses. Mayo Clin Proc 75(7):711–721
12. 12. SR Pliszka 2005 The neuropsychopharmacology of attention-deficit/hyperactivity disorder Biol Psychiatry 57 11 1385 1390 15950012 10.1016/j.biopsych.2004.08.026 Pliszka SR (2005) The neuropsychopharmacology of attention-deficit/hyperactivity disorder. Biol Psychiatry 57(11):1385–1390
13. 13. LL Barrickman PJ Perry AJ Allen S Kuperman SV Arndt KJ Herrmann 1995 Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder J Am Acad Child Adolesc Psychiatry 34 5 649 657 7775360 10.1097/00004583-199505000-00017 Barrickman LL, Perry PJ, Allen AJ, Kuperman S, Arndt SV, Herrmann KJ et al (1995) Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34(5):649–657
14. 14. CK Conners CD Casat CT Gualtieri E Weller M Reader A Reiss 1996 Bupropion hydrochloride in attention deficit disorder with hyperactivity J Am Acad Child Adolesc Psychiatry 35 10 1314 1321 8885585 10.1097/00004583-199610000-00018 Conners CK, Casat CD, Gualtieri CT, Weller E, Reader M, Reiss A et al (1996) Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 35(10):1314–1321
15. 15. RS Rosenfeld L Hellman TF Gallagher 1972 Metabolism and interconversion of dehydroisoandrosterone and dehydroisoandrosterone sulfate J Clin Endocrinol Metab 35 2 187 193 4262844 10.1210/jcem-35-2-187 Rosenfeld RS, Hellman L, Gallagher TF (1972) Metabolism and interconversion of dehydroisoandrosterone and dehydroisoandrosterone sulfate. J Clin Endocrinol Metab 35(2):187–193
16. 16. C Longcope 1996 Dehydroepiandrosterone metabolism J Endocrinol 150 Suppl S125 127 8943796 Longcope C (1996) Dehydroepiandrosterone metabolism. J Endocrinol 150(Suppl):S125–127
17. 17. GJ DuPaul TJ Power AD Anastopoulos R Reid 1998 The ADHD Rating Scale-IV: Checklists, norms, and clinical interpretation Guilford Press New York DuPaul GJ, Power TJ, Anastopoulos AD, Reid R (1998) The ADHD Rating Scale-IV: Checklists, norms, and clinical interpretation. Guilford Press, New York
18. 18. YK So JS Noh YS Kim SG Ko Y-J Koh 2002 The reliability and validity of Korean parent and teacher ADHD rating scale J Korean Neuropsychiatr Assoc 41 2 283 289 So YK, Noh JS, Kim YS, Ko SG, Koh Y-J (2002) The reliability and validity of Korean parent and teacher ADHD rating scale. J Korean Neuropsychiatr Assoc 41(2):283–289
19. 19. MS Shin S Cho SY Chun K-E Hong 2000 A study of the development and standardization of ADHD diagnostic system Korean J Child Adol Psychiatr 11 1 91 99 Shin MS, Cho S, Chun SY, Hong K-E (2000) A study of the development and standardization of ADHD diagnostic system. Korean J Child Adol Psychiatr 11(1):91–99
20. 20. FS Salek KL Bigos PD Kroboth 2002 The influence of hormones and pharmaceutical agents on DHEA and DHEA-S concentrations: a review of clinical studies J Clin Pharmacol 42 3 247 266 11865961 10.1177/00912700222011274 Salek FS, Bigos KL, Kroboth PD (2002) The influence of hormones and pharmaceutical agents on DHEA and DHEA-S concentrations: a review of clinical studies. J Clin Pharmacol 42(3):247–266
21. 21. RD Strous R Maayan R Lapidus R Stryjer M Lustig M Kotler 2003 Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia Arch Gen Psychiatry 60 2 133 141 12578430 10.1001/archpsyc.60.2.133 Strous RD, Maayan R, Lapidus R, Stryjer R, Lustig M, Kotler M et al (2003) Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen Psychiatry 60(2):133–141
22. 22. S Demirgoren MD Majewska CE Spivak ED London 1991 Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor Neuroscience 45 1 127 135 1661387 10.1016/0306-4522(91)90109-2 Demirgoren S, Majewska MD, Spivak CE, London ED (1991) Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor. Neuroscience 45(1):127–135
23. 23. R Bergeron C Montigny de G Debonnel 1996 Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors J Neurosci 16 3 1193 1202 8558248 Bergeron R, de Montigny C, Debonnel G (1996) Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J␣Neurosci 16(3):1193–1202
24. 24. M Lehohla L Kellaway VA Russell 2004 NMDA receptor function in the prefrontal cortex of a rat model for attention-deficit hyperactivity disorder Metab Brain Dis 19 1–2 35 42 15214504 10.1023/B:MEBR.0000027415.75432.ad Lehohla M, Kellaway L, Russell VA (2004) NMDA receptor function in the prefrontal cortex of a rat model for attention-deficit hyperactivity disorder. Metab Brain Dis 19(1–2):35–42
25. 25. EP Guazzo PJ Kirkpatrick IM Goodyer HM Shiers J Herbert 1996 Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age J Clin Endocrinol Metab 81 11 3951 3960 8923843 10.1210/jc.81.11.3951 Guazzo EP, Kirkpatrick PJ, Goodyer IM, Shiers HM, Herbert J (1996) Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J Clin Endocrinol Metab 81(11):3951–3960